Director, Search & Evaluation Early Ta Lead Immunology

CSL Behring

Melbourne, Australia
Base: $232,000 - $284,000 usd (waltham ma); incent...
12+ years biopharma experience
External innovation leadership
Early-stage deal closing
The role involves leading proactive sourcing efforts for preclinical and Phase 1 assets aligned with therapeutic area strategy

Job Summary

  • The role involves leading proactive sourcing efforts for preclinical and Phase 1 assets aligned with therapeutic area strategy.
  • Candidates will co-lead internal meetings to evaluate New Product Opportunities and drive cross-functional due diligence for governance decisions.
  • CSL Behring is a global biotherapeutics leader employing 32,000 people who deliver lifesaving therapies to over 100 countries.

Matching Summary

The role involves leading proactive sourcing efforts for preclinical and Phase 1 assets aligned with therapeutic area strategy.

Salary

Base: $232,000 - $284,000 USD (Waltham MA); Incentive compensation and equity included; Benefits not specified

Skills & Requirements

Must-have

  • 12+ years biopharma experience
  • External innovation leadership
  • Early-stage deal closing
  • Immunology or Hematology expertise
  • Cross-functional due diligence

Nice-to-have

  • Strong biotech network
  • Academic collaboration relationships
  • Agile team environment
  • Strategic partnership building

Key Requirements

  • Advanced degree (PhD, MD, or equivalent)
  • Deep scientific expertise in specified therapeutic areas
  • Proven track record of closing early-stage deals
  • 12+ years in biopharma industry

Work Rights

Not specified

Tailored Resume

Cover Letter